These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1296 related articles for article (PubMed ID: 31419585)

  • 41. A platform for actively loading cargo RNA to elucidate limiting steps in EV-mediated delivery.
    Hung ME; Leonard JN
    J Extracell Vesicles; 2016; 5():31027. PubMed ID: 27189348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Extracellular vesicles in respiratory disease.
    Carnino JM; Lee H
    Adv Clin Chem; 2022; 108():105-127. PubMed ID: 35659058
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Are extracellular vesicles new hope in clinical drug delivery for neurological disorders?
    Muhammad SA
    Neurochem Int; 2021 Mar; 144():104955. PubMed ID: 33412233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Engineered extracellular vesicles: A novel platform for cancer combination therapy and cancer immunotherapy.
    Ahmadi M; Hassanpour M; Rezaie J
    Life Sci; 2022 Nov; 308():120935. PubMed ID: 36075472
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic potential of RNA-enriched extracellular vesicles: The next generation in RNA delivery via biogenic nanoparticles.
    Muskan M; Abeysinghe P; Cecchin R; Branscome H; Morris KV; Kashanchi F
    Mol Ther; 2024 Sep; 32(9):2939-2949. PubMed ID: 38414242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Targeting Inflammatory Vasculature by Extracellular Vesicles.
    Wang S; Dong X; Gao J; Wang Z
    AAPS J; 2018 Feb; 20(2):37. PubMed ID: 29484558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extracellular vesicles as novel drug delivery systems to target cancer and other diseases: Recent advancements and future perspectives.
    Ramesh D; Bakkannavar S; Bhat VR; Sharan K
    F1000Res; 2023; 12():329. PubMed ID: 37868300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced Loading of Functional miRNA Cargo via pH Gradient Modification of Extracellular Vesicles.
    Jeyaram A; Lamichhane TN; Wang S; Zou L; Dahal E; Kronstadt SM; Levy D; Parajuli B; Knudsen DR; Chao W; Jay SM
    Mol Ther; 2020 Mar; 28(3):975-985. PubMed ID: 31911034
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Milk-derived Extracellular Vesicles for Therapeutic Delivery of Small Interfering RNAs.
    Matsuda A; Patel T
    Methods Mol Biol; 2018; 1740():187-197. PubMed ID: 29388145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integrated transcriptomic and proteomic analysis of the molecular cargo of extracellular vesicles derived from porcine adipose tissue-derived mesenchymal stem cells.
    Eirin A; Zhu XY; Puranik AS; Woollard JR; Tang H; Dasari S; Lerman A; van Wijnen AJ; Lerman LO
    PLoS One; 2017; 12(3):e0174303. PubMed ID: 28333993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extracellular vesicles for tissue repair and regeneration: Evidence, challenges and opportunities.
    Nagelkerke A; Ojansivu M; van der Koog L; Whittaker TE; Cunnane EM; Silva AM; Dekker N; Stevens MM
    Adv Drug Deliv Rev; 2021 Aug; 175():113775. PubMed ID: 33872693
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preservation and Storage Stability of Extracellular Vesicles for Therapeutic Applications.
    Jeyaram A; Jay SM
    AAPS J; 2017 Nov; 20(1):1. PubMed ID: 29181730
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stem cells derived extracellular vesicles: A promising nanomedicine for drug delivery system.
    Rezaie J; Nejati V; Mahmoodi M; Ahmadi M
    Biochem Pharmacol; 2022 Sep; 203():115167. PubMed ID: 35820499
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time.
    Kooijmans SAA; Fliervoet LAL; van der Meel R; Fens MHAM; Heijnen HFG; van Bergen En Henegouwen PMP; Vader P; Schiffelers RM
    J Control Release; 2016 Feb; 224():77-85. PubMed ID: 26773767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. On the Choice of the Extracellular Vesicles for Therapeutic Purposes.
    Campanella C; Caruso Bavisotto C; Logozzi M; Marino Gammazza A; Mizzoni D; Cappello F; Fais S
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30634425
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current challenges and future directions for engineering extracellular vesicles for heart, lung, blood and sleep diseases.
    Li G; Chen T; Dahlman J; Eniola-Adefeso L; Ghiran IC; Kurre P; Lam WA; Lang JK; Marbán E; Martín P; Momma S; Moos M; Nelson DJ; Raffai RL; Ren X; Sluijter JPG; Stott SL; Vunjak-Novakovic G; Walker ND; Wang Z; Witwer KW; Yang PC; Lundberg MS; Ochocinska MJ; Wong R; Zhou G; Chan SY; Das S; Sundd P
    J Extracell Vesicles; 2023 Feb; 12(2):e12305. PubMed ID: 36775986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Basic Guide for Approaching Drug Delivery with Extracellular Vesicles.
    Brezgin S; Danilik O; Yudaeva A; Kachanov A; Kostyusheva A; Karandashov I; Ponomareva N; Zamyatnin AA; Parodi A; Chulanov V; Kostyushev D
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408730
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors.
    Femminò S; Penna C; Margarita S; Comità S; Brizzi MF; Pagliaro P
    Vascul Pharmacol; 2020 Dec; 135():106790. PubMed ID: 32861822
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functionalized extracellular vesicles as advanced therapeutic nanodelivery systems.
    Lu M; Xing H; Xun Z; Yang T; Zhao X; Cai C; Wang D; Ding P
    Eur J Pharm Sci; 2018 Aug; 121():34-46. PubMed ID: 29733979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 65.